What question did this study set out to answer?

To review the historical development, methodological hurdles, and therapeutic evolution of gene transfer into hematopoietic stem cells for treating severe hemoglobinopathies.

January 1, 1999Cold Spring Harbor Monograph Archive

15 The Hematopoietic System as a Target for Gene Therapy

View Full Paper

Ask AI

Bookmark

To review the historical development, methodological hurdles, and therapeutic evolution of gene transfer into hematopoietic stem cells for treating severe hemoglobinopathies.
Examined early molecular cloning breakthroughs of globin genes and initial calcium-phosphate-mediated DNA transfection techniques.
Evaluated preclinical outcomes in murine models alongside initial, unauthorized clinical attempts to treat severe β-thalassemia.
Early clinical efforts utilizing calcium-phosphate-mediated DNA transfection suffered from exceptionally low efficiency of stem cell transduction and genomic integration.
Rigorous preclinical research in murine and large-animal systems subsequently established reproducible methods and regulatory frameworks required for safe human trials.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Narrative review traces the development of hematopoietic stem cell gene therapy for severe hemoglobin disorders, highlighting early technical limitations and regulatory milestones.

Cite This Study

Sorrentino et al. (1999) studied this question.

synapsesocial.com/papers/6a85778ef03ba6f1e320200c https://doi.org/10.1101/087969528.36.351

View Full Paper

Ask AI

Bookmark

Implication

Narrative review traces the development of hematopoietic stem cell gene therapy for severe hemoglobin disorders, highlighting early technical limitations and regulatory milestones.

15 The Hematopoietic System as a Target for Gene Therapy

Key Points

Discussion

Implication

Cite This Study

15 The Hematopoietic System as a Target for Gene Therapy

Key Points

Discussion

Implication

Cite This Study

Keep reading

Keep reading